A Trump administration order to freeze communication at the National Institutes of Health has disrupted scientific research ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

The Trump administration has appointed Matthew Memoli, a veteran researcher who was critical of the U.S. response to the ...

The interim leader of the National Institutes of Health gave some clarification tied to Trump administrations restrictions on ...

Health and research systems like Penn Medicine and the Children’s Hospital of Philadelphia were among those affected by 1968 ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...

The U.S. Centers for Disease Control and Prevention and other federal health agencies on Friday took down webpages with ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.